Padagis US LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and specialty medications. Founded in 2018, the company has quickly established itself as a trusted provider, focusing on areas such as injectables and complex formulations. With a commitment to innovation, Padagis offers a diverse portfolio of products that stand out for their quality and efficacy. The company operates primarily in the US market, with a growing presence in international regions. Notable achievements include securing multiple FDA approvals, which underscore its dedication to meeting stringent regulatory standards. As a result, Padagis US LLC is well-positioned to contribute significantly to the healthcare landscape, ensuring access to essential medications for patients across various therapeutic areas.
How does Padagis US LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Padagis US LLC's score of 43 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Padagis US LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Perrigo Company plc, which means that any emissions data or climate commitments may be inherited from its parent organisation. As of now, Padagis US LLC has not established specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of documented reduction targets suggests that the company may still be in the early stages of developing its climate strategy. Given its relationship with Perrigo Company plc, any relevant emissions data or climate commitments would likely be aligned with the parent company's sustainability goals. However, without specific figures or targets from either Padagis US LLC or Perrigo Company plc, it is challenging to provide a detailed overview of their carbon footprint or climate commitments. In summary, while Padagis US LLC is part of a larger corporate family that may have sustainability initiatives, there is currently no available emissions data or defined climate commitments specific to the company itself.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | - | - | - | - | - | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 
Padagis US LLC's Scope 3 emissions, which decreased by 12% last year and decreased by approximately 12% since 2022, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Capital Goods" being the largest emissions source at 71% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Padagis US LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.